Blood contact activation: pathophysiological effects and therapeutic approaches.
Hornick
P
P
Departments of Cardiothoracic Surgery and Immunology, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.
George
A
A
D000818:Animals; D000917:Antibody Formation; D007611:Aprotinin / Q000627:therapeutic use; D001773:Blood Cells / Q000502:physiology*; D001792:Blood Platelets / Q000502:physiology; D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D003165:Complement System Proteins / Q000502:physiology; D006801:Humans; D007249:Inflammation / Q000209:etiology* / Q000628:therapy; D009504:Neutrophils / Q000502:physiology; D011183:Postoperative Complications / Q000209:etiology; D019106:Postoperative Hemorrhage / Q000209:etiology* / Q000628:therapy
D003165:Complement System Proteins; D007611:Aprotinin